Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 08:00 ET | Source: Callio Therapeutics

Callio Therapeutics Doses First Patient in Phase I Clinical Trial of Dual-Payload ADC CLIO-8221 in Advanced HER2-Expressing Solid Tumors

Callio Therapeutics is actively developing a pipeline of promising dual-payload ADCs featuring rationally designed payload combinations for hard-to-treat tumors CLIO-8221 is the first program from...
March 23, 2026 16:05 ET | Source: Sutro Biopharma, Inc.

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

– Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in mid-2026 – – Company announced first wholly owned...
March 23, 2026 09:23 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech’s New York Reference Laboratory DUBLIN and NEW YORK,...
March 23, 2026 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Strong financial position with cash, cash equivalents and marketable securities of $91.5M as of December 2025 $2.25B Moderna global settlement for infringement of lipid nanoparticle (LNP) delivery...
March 23, 2026 07:00 ET | Source: Tessera Therapeutics

Tessera Therapeutics Receives Grant to Advance In Vivo Gene Writing Approaches Towards a Potential Human Immunodeficiency Virus (HIV) Cure

SOMERVILLE, Mass., March 23, 2026 (GLOBE NEWSWIRE) -- SOMERVILLE, Mass., March 23, 2026 /GLOBE NEWSWIRE/ Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in...
March 23, 2026 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...
March 20, 2026 18:00 ET | Source: Brook Gaming

Wingman P5 by Brook Gaming: True wireless & near-zero latency for native PS5, PS4 & PC gaming

NEW TAIPEI CITY, Taiwan, March 20, 2026 (GLOBE NEWSWIRE) -- Brook Gaming, the global leader in cross-platform controller solutions, today announced the global launch of the Wingman P5. This...
March 20, 2026 07:39 ET | Source: Mordor Intelligence

DNA Sequencing Market to Expand at 18%+ CAGR by 2031 as Genomics Research and Precision Medicine Drive Global Adoption, Says Mordor Intelligence

Hyderabad, March 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence’s latest report, the global DNA sequencing market is witnessing strong growth, driven by advancements in genomic...
March 19, 2026 19:21 ET | Source: Cellectis Inc.

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoing Phase 1: 83% ORR at RP2D and 100% ORR in the target Phase 2 populationIn target Phase 2 population: 100% of patients became...
March 19, 2026 08:29 ET | Source: Waldencast plc

Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the...